Beauty Health CO Form 4 insider transactions

Brent Saunders, a director at Beauty Health Co, acquired 40,450 shares of Class A Common Stock at $1.08 per share on August 12, 2024.

Michael Monahan, CFO of Beauty Health Co, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Director Desiree Gruber reports acquisition of restricted stock units in Beauty Health Co, increasing her holdings.

Director Brian Christopher Miller reported the acquisition of Beauty Health Co Class A Common Stock through a grant of restricted stock units.

Doug K. Schillinger, a director of Beauty Health Co, reported the acquisition of restricted stock units.

Director Michelle C. Kerrick reports acquisition of restricted stock units in Beauty Health Co, increasing her holdings.

Director Julius Few reports acquisition of restricted stock units in Beauty Health Co, increasing his holdings.

Director Michael Capellas reports acquisition of restricted stock units in Beauty Health Co.

Brent Saunders, Chairman of Beauty Health Co., reports transactions involving Class A Common Stock, including shares withheld for tax obligations and a grant of restricted stock units.

Daniel Watson, Chief Revenue Officer of Beauty Health Co, reports the withholding of shares to cover tax obligations and acquisitions under the Employee Stock Purchase Plan.

Marla Malcolm Beck, President and CEO of Beauty Health Co, reported the disposal of Class A Common Stock to cover tax withholding requirements on vesting restricted stock units.

Daniel Copell Watson, Chief Revenue Officer of Beauty Health Co, received a grant of restricted stock units vesting over three years.

Michael Monahan, CFO of Beauty Health Co., reports the acquisition of restricted stock units.

Marla Malcolm Beck, President and CEO of Beauty Health Co., was granted restricted stock units vesting over three years, as reported in a recent SEC filing.